US2006275869A1PendingUtilityA1
Novel matrix metalloproteinases
Est. expiryMay 22, 2020(expired)· nominal 20-yr term from priority
C12N 9/6491C12N 2799/021
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides genes encoding novel matrix metalloproteinases termed MMP; constructs and recombinant host cells incorporating the genes; the MMP polypeptides encoded by the genes; antibodies to the MMP polypeptides; and methods of making and using all of the foregoing.
Claims
exact text as granted — not AI-modified1 . An isolated nucleic acid molecule comprising a nucleotide sequence that encodes a polypeptide comprising an amino acid sequence homologous to sequences selected from the group consisting of: SEQ ID NO:4 to SEQ ID NO:6; said nucleic acid molecule encoding at least a portion of MMP, with the proviso that the nucleotide sequence is not SEQ ID NO:7.
2 . The isolated nucleic acid molecule of claim 1 comprising a sequence that encodes a polypeptide comprising a sequence selected from the group consisting of SEQ ID NO:4 to SEQ ID NO:6.
3 . The isolated nucleic acid molecule of claim 1 comprising a sequence homologous to a sequence selected from the group consisting of SEQ ID NO:1 to SEQ ID NO:3.
4 . The isolated nucleic acid molecule of claim 1 comprising a sequence selected from the group of sequences consisting of SEQ ID NO:1 to SEQ ID NO:3.
5 . The isolated nucleic acid molecule of claim 1 wherein said nucleic acid molecule is DNA.
6 . The isolated nucleic acid molecule of claim 1 wherein said nucleic acid molecule is RNA.
7 . An expression vector comprising a nucleic acid molecule of any one of claims 1
8 . The expression vector of claim 7 wherein said nucleic acid molecule comprises a sequence selected from the group of sequences consisting of SEQ ID NO:1 to SEQ ID NO:3.
9 . The expression vector of claim 7 wherein said vector is a plasmid.
10 . The expression vector of claim 7 wherein said vector is a viral particle.
11 . The expression vector of claim 10 wherein said vector is selected from the group consisting of adenoviruses, baculoviruses, parvoviruses, herpesviruses, poxviruses, adeno-associated viruses, Semliki Forest viruses, vaccinia viruses, and retroviruses.Join the waitlist — get patent alerts
Track US2006275869A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.